These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 38455236)

  • 1. Erratum: A pilot study to understand and respond to loss, theft, and misplacement of hepatitis C treatment medication for people who inject drugs.
    Clin Liver Dis (Hoboken); 2024; 23(1):e0120. PubMed ID: 38455236
    [No Abstract]   [Full Text] [Related]  

  • 2. A pilot study to understand and respond to loss, theft, and misplacement of hepatitis C treatment medication for people who inject drugs.
    Morris MD; McDonell C; Kim RG; Laguardia Y; Kanner R; Price JC
    Clin Liver Dis (Hoboken); 2023 Sep; 22(3):81-84. PubMed ID: 37799636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the Impacts of Prevention and Treatment Interventions on Hepatitis C Among People Who Inject Drugs in China.
    Fang K; Wang HL; Lin Y; Li S; Wu J
    Infect Dis Ther; 2023 Apr; 12(4):1043-1055. PubMed ID: 36894824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global, regional, and country-level coverage of testing and treatment for HIV and hepatitis C infection among people who inject drugs: a systematic review.
    Hajarizadeh B; Kairouz A; Ottaviano S; Ireland J; Willing A; Cunningham E; Webb P; Colledge-Frisby S; Wheeler A; Leung J; Tran LT; Price O; Vickerman P; Farrell M; Hickman M; Dore GJ; Bergenström A; Degenhardt L; Grebely J
    Lancet Glob Health; 2023 Dec; 11(12):e1885-e1898. PubMed ID: 37973339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of injecting drug use and HIV, hepatitis B, and hepatitis C in people who inject drugs in the Eastern Mediterranean region: a systematic review and meta-analysis.
    Aghaei AM; Gholami J; Sangchooli A; Rostam-Abadi Y; Olamazadeh S; Ardeshir M; Baheshmat S; Shadloo B; Taj M; Saeed K; Rahimi-Movaghar A
    Lancet Glob Health; 2023 Aug; 11(8):e1225-e1237. PubMed ID: 37474230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Hepatitis C Awareness Through to Treatment (HepCATT) study: improving the cascade of care for hepatitis C virus-infected people who inject drugs in England.
    Harrison GI; Murray K; Gore R; Lee P; Sreedharan A; Richardson P; Hughes AJ; Wiselka M; Gelson W; Unitt E; Ratcliff K; Orton A; Trinder K; Simpson C; Ryder SD; Oelbaum S; Foster GR; Christian A; Smith S; Thomson BJ; Reynolds R; Harris M; Hickman M; Irving WL
    Addiction; 2019 Jun; 114(6):1113-1122. PubMed ID: 30694582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accessing hepatitis C direct acting antivirals among people living with hepatitis C: a qualitative study.
    Antoniou T; Pritlove C; Shearer D; Tadrous M; Shah H; Gomes T
    Int J Equity Health; 2023 Jun; 22(1):112. PubMed ID: 37280588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus treatment as prevention in an extended network of people who inject drugs in the USA: a modelling study.
    Zelenev A; Li J; Mazhnaya A; Basu S; Altice FL
    Lancet Infect Dis; 2018 Feb; 18(2):215-224. PubMed ID: 29153265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of assisted partner services for people who inject drugs in Kenya to identify partners living with HIV and hepatitis C virus infection: a prospective cohort study.
    Monroe-Wise A; Mbogo L; Sambai B; Ludwig-Barron N; Guthrie BL; Bukusi D; Chohan BH; Masyuko S; Scott J; Juma E; Macharia P; Kingston H; Sinkele W; Gitau E; Bosire R; Musyoki H; Herbeck J; Farquhar C
    Lancet Glob Health; 2024 May; 12(5):e859-e867. PubMed ID: 38614633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selecting a theoretical framework to explore the social and cognitive uncertainty that hepatitis C treatment represents for people who inject drugs.
    Carlson G; Crane TE; Taylor-Piliae RE
    Appl Nurs Res; 2020 Dec; 56():151339. PubMed ID: 32907767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Video-Observed Treatment Strategy to Improve Adherence to Treatment Among Persons Who Inject Drugs Infected With Hepatitis C Virus: Qualitative Study of Stakeholder Perceptions and Experiences.
    Karasz A; Merchant K; Arnsten J; Feinberg J; Kim AY; Lum PJ; McKee MD; Mehta SH; Meissner P; Norton BL; Page K; Pericot-Valverde I; Singh R; Stein E; Taylor LE; Tsui JI; Wagner K; Litwin A
    J Med Internet Res; 2023 Jun; 25():e38176. PubMed ID: 37266986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of direct and indirect social and spatial ties in the diffusion of HIV and HCV among people who inject drugs: a cross-sectional community-based network analysis in New Delhi, India.
    Clipman SJ; Mehta SH; Srikrishnan AK; Zook KJ; Duggal P; Mohapatra S; Shanmugam S; Nandagopal P; Kumar MS; Ogburn E; Lucas GM; Latkin CA; Solomon SS
    Elife; 2021 Aug; 10():. PubMed ID: 34342266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of and risk factors for hepatitis C virus antibody among people who inject drugs in Cambodia: a national biological and behavioral survey.
    Yi S; Mun P; Chhoun P; Chann N; Tuot S; Mburu G
    Harm Reduct J; 2019 Apr; 16(1):29. PubMed ID: 31036011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis.
    Cunningham EB; Wheeler A; Hajarizadeh B; French CE; Roche R; Marshall AD; Fontaine G; Conway A; Bajis S; Valencia BM; Presseau J; Ward JW; Degenhardt L; Dore GJ; Hickman M; Vickerman P; Grebely J
    Int J Drug Policy; 2023 Jan; 111():103917. PubMed ID: 36542883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study.
    Valerio H; Alavi M; Conway A; Silk D; Treloar C; Martinello M; Milat A; Dunlop A; Murray C; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Stevens A; Prain B; Hayllar J; Reid D; Montebello M; Wade A; Christmass M; Cock V; Dore GJ; Grebely J;
    Int J Drug Policy; 2022 Jul; 105():103706. PubMed ID: 35533635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers to hepatitis C treatment among secondary needle and syringe program clients and opportunities to intervene.
    Gunn J; McNally S; Ryan J; Layton C; Bryant M; Walker S; O'Mahony C; Pedrana A
    Int J Drug Policy; 2021 Oct; 96():103387. PubMed ID: 34330571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review.
    Degenhardt L; Webb P; Colledge-Frisby S; Ireland J; Wheeler A; Ottaviano S; Willing A; Kairouz A; Cunningham EB; Hajarizadeh B; Leung J; Tran LT; Price O; Peacock A; Vickerman P; Farrell M; Dore GJ; Hickman M; Grebely J
    Lancet Glob Health; 2023 May; 11(5):e659-e672. PubMed ID: 36996857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of scaling-up HCV prevention and treatment in the United States for people who inject drugs.
    Barbosa C; Fraser H; Hoerger TJ; Leib A; Havens JR; Young A; Kral A; Page K; Evans J; Zibbell J; Hariri S; Vellozzi C; Nerlander L; Ward JW; Vickerman P
    Addiction; 2019 Dec; 114(12):2267-2278. PubMed ID: 31307116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harm Reduction Coverage and Hepatitis C Incidence: Findings From a Cohort of People Who Inject Drugs.
    Minoyan N; Artenie AA; Zang G; Jutras-Aswad D; Turcotte MÈ; Bruneau J
    Am J Prev Med; 2020 Jun; 58(6):845-853. PubMed ID: 32444003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability of Rapid Point-of-Care Hepatitis C Tests Among People Who Inject Drugs and Utilize Syringe-Exchange Programs.
    Barocas JA; Linas BP; Kim AY; Fangman J; Westergaard RP
    Open Forum Infect Dis; 2016 Mar; 3(2):ofw075. PubMed ID: 27191007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.